Top pharma official rejects idea of free Covid-19 vaccine for all
A leading representative of the pharmaceutical industry has downplayed the idea of a vaccine against the new coronavirus that is “free for all” when available.
This content was published on
2 minutes
Keystone-SDA/sb
Português
pt
Indústria farmacêutica rejeita ideia de vacina grátis para todos
In Switzerland, where the health system works well, it doesn’t make sense to have access to a free vaccine, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), told reporters in a virtual briefing on Monday.
Cueni said he shared the objective of fair, widespread and low-cost access to products around the world. But he said a global distribution system piloted by the Geneva-based World Health Organization (WHO) was needed to lower prices in poorer countries.
“I would expect countries like Switzerland to show solidarity and a willingness to pay a bit more than other countries, where I hope patients can get free vaccines,” he said. “This is a lot more realistic than to say everyone should have access to free vaccines.”
More
More
Covid-19 to dominate ‘unprecedented’ virtual World Health Assembly
This content was published on
Fair access to vaccines and treatments, and an evaluation of WHO’s response to the pandemic are set to dominate the World Health Assembly on Monday.
Cueni made the comments as health ministers from around the world were taking part in a virtual meeting of the World Health Assembly, the WHO’s decision-making body. During the two-day session states will vote on an EU resolution that calls for “universal, timely and equitable access” to Covid-19 treatments and vaccines against the disease.
‘People’s vaccine’
In a parallel initiative, around 150 world leaders and experts signed an open letterExternal link urging health ministers at the event to rally behind a “people’s vaccine” made available for all people, in all countries, free of charge without patent restrictions.
Scientists are rushing to find treatments and vaccines for a disease that has killed over 310,000 people worldwide. More than 120 vaccines are currently being developed globally, with eight in the clinical trial phase. But experts say the process could take years and may not happen at all.
Cueni estimates it will take a year before a vaccine can be mass produced. But when it is ready, not everyone will be able to get it straight away; health workers will be first in line, he added.
The IFPMA is a partner of a major initiative launched earlier this month by the EU, Britain, Norway, Japan, Canada and Saudi Arabia – but without the United States – which raised $8 billion (CHF7.7 billion) in pledges for Covid-19 vaccines and treatments.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid-19 to dominate ‘unprecedented’ virtual World Health Assembly
This content was published on
Fair access to vaccines and treatments, and an evaluation of WHO's response to the pandemic are set to dominate the World Health Assembly on Monday.
Global cooperation needed to prevent Covid-19 drugs ‘free-for-all’
This content was published on
Weaker countries may be pushed aside in the scramble for effective drugs to fight coronavirus, an infectious diseases expert fears.
Covid-19 is both threat and opportunity for Swiss biotech
This content was published on
Although the coronavirus pandemic is the Swiss biotech industry’s time to shine, it has left many smaller firms struggling to survive.
WHO and Roche launch trials of potential coronavirus treatments
This content was published on
Roche is launching a clinical trial of a potential new Covid-19 drug, adding to rapidly growing investments in combating coronavirus.
WHO director defends Chinese over coronavirus criticism
This content was published on
The new coronavirus is an epidemic with “many battlefields”, but it can be stopped via the drastic measures being imposed, says a WHO director.
This content was published on
There is much we still don’t know about the new coronavirus. Meanwhile, an anxious world fills the knowledge vacuum with rumour, and misinformation.
WHO adopts watered-down resolution on drug transparency
This content was published on
The World Health Organization (WHO) has adopted a resolution to improve transparency on drug prices but some people say it doesn't go far enough.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.